Targeting the EWS–FLI1 transcription factor in Ewing sarcoma

Conclusions The encouraging clinical benefit observed with the combination and its good tolerability deserves further investigation in Ewing sarcoma.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research